Analyst Research

Report Title Price
Provider: Directors Deals Ltd.
Provider: GlobalData
Provider: Thomson Reuters Stock Report
Provider: Peel Hunt

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Immunodiagnostic Systems Holdings PLC Sees FY 2013 Results To Be In Line With Board's Expectations

Wednesday, 10 Apr 2013 02:00am EDT 

Immunodiagnostic Systems Holdings PLC announced that results for fiscal 2013 are anticipated to be in line with the Board's expectations, as set out at the interim results in November 2012. Total revenues are expected to be GBP49.8 million (2012: GBP53.7 million). The revenue performance is encouraging particularly given the tough trading environment due to a rapidly declining manual 25OH Vitamin D market, significantly increased automated vitamin D competition and ongoing laboratory consolidation, predominantly in the French market. 

Company Quote

0.0 +0.00%
19 Dec 2014